Harry Visser

941 total citations
12 papers, 218 citations indexed

About

Harry Visser is a scholar working on Rheumatology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Harry Visser has authored 12 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Pharmacology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Harry Visser's work include Inflammatory mediators and NSAID effects (5 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Bone and Joint Diseases (2 papers). Harry Visser is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Bone and Joint Diseases (2 papers). Harry Visser collaborates with scholars based in Netherlands, United Kingdom and Switzerland. Harry Visser's co-authors include J. Freek van Iwaarden, Henk P. Haagsman, J. Verhoef, L M van Golde, Jos A. G. van Strijp, Harrie Weinans, Laura B. Creemers, Nina Woike, Imke Rudnik‐Jansen and Pieter J. Emans and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Osteoarthritis and Cartilage.

In The Last Decade

Harry Visser

11 papers receiving 211 citations

Peers

Harry Visser
Harry Visser
Citations per year, relative to Harry Visser Harry Visser (= 1×) peers Marcello Montagni

Countries citing papers authored by Harry Visser

Since Specialization
Citations

This map shows the geographic impact of Harry Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Visser more than expected).

Fields of papers citing papers by Harry Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Visser. The network helps show where Harry Visser may publish in the future.

Co-authorship network of co-authors of Harry Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Visser. A scholar is included among the top collaborators of Harry Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Visser. Harry Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Visser, Harry, F.P.J.G. Lafeber, K. Coeleveld, et al.. (2021). IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model. Cartilage. 13(2_suppl). 1155S–1164S. 5 indexed citations
2.
Korthagen, N.M., et al.. (2019). Folate receptor positive macrophages in rat models for OA: phenotype switch in response to anti-inflammatory medication. Osteoarthritis and Cartilage. 27. S373–S373.
3.
Visser, Harry, et al.. (2018). IL4-10 fusion protein as a disease modifying therapy for osteoarthritis evaluated in a rat groove model in vivo. Osteoarthritis and Cartilage. 26. S292–S292. 1 indexed citations
4.
Visser, Harry, S.C. Mastbergen, Paco M J Welsing, et al.. (2018). Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation. PLoS ONE. 13(4). e0196308–e0196308. 12 indexed citations
6.
Tellegen, Anna R., Imke Rudnik‐Jansen, Behdad Pouran, et al.. (2018). Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis. Drug Delivery. 25(1). 1438–1447. 44 indexed citations
7.
Visser, Harry, S.C. Mastbergen, David A. Barrett, et al.. (2017). Quantification of systemic and local lipid-derived inflammatory mediators in a rat OA model. Osteoarthritis and Cartilage. 25. S98–S99. 1 indexed citations
8.
Visser, Harry, N.M. Korthagen, Cristina Müller, et al.. (2017). A New Dota-Folate Conjugate (CM09) For Imaging of Folate Receptor Expressing Macrophages in a Rat Model of Osteoarthritis. Osteoarthritis and Cartilage. 25. S263–S264. 1 indexed citations
9.
Visser, Harry, et al.. (2016). The groove model of tibia-femoral osteoarthritis in the rat. Osteoarthritis and Cartilage. 24. S400–S401. 1 indexed citations
10.
Mello, Norah M. van, Femke Mol, Albert H. Adriaanse, et al.. (2008). The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial. BMC Women s Health. 8(1). 10–10. 27 indexed citations
11.
Kremer, Jan A.M. & Harry Visser. (2008). [Testicular sperm extraction (TESE) with intracytoplasmic sperm injection (ICSI) now allowed in the Netherlands].. PubMed. 152(3). 164–6. 4 indexed citations
12.
Iwaarden, J. Freek van, Jos A. G. van Strijp, Harry Visser, et al.. (1992). Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.. Journal of Biological Chemistry. 267(35). 25039–25043. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026